Methods for humanizing rabbit monoclonal antibodies

• US 20050033031A1
• Filed: 08/07/2003
• Published: 02/10/2005
• Est. Priority Date: 08/07/2003
• Status: Abandoned Application

• Current Assignee: Epitomics Incorporated (Abcam Plc)
• Original Assignee: Epitomics Incorporated (Abcam Plc)
• Inventors: Couto, Fernando Jose Rebelo Do
• Application Number:
  US10/637,317
• Publication Number:
  US 20050033031A1
• Time in Patent Office: Days
• US Class Current: 530/388.150
• CPC Class Codes: C07H 21/04 with deoxyribosyl as saccharide radical
• CPC Class Codes: C07K 16/2839 against the integrin superfamily
• CPC Class Codes: C07K 16/461 Igs containing Ig-regions, -domains or -residues form different species
• CPC Class Codes: C07K 2317/565 Complementarity determining region [CDR]
• CPC Class Codes: C07K 2317/567 Framework region [FR]

Abstract

The invention provides a method for humanizing a rabbit monoclonal antibody. In general, the method involves comparing an amino acid sequences of a parent rabbit antibody to the amino acid sequences of a similar human antibody, and altering the amino acid sequence of the parent rabbit antibody such its framework regions are more similar in sequence to the equivalent framework regions of the similar human antibody. In many embodiments, amino acids in the parent rabbit antibody that are not CDR contact residues, interchain contact residues, or buried residues, are not modified. The invention further provides nucleic acids encoding the subject antibodies, as well as vectors and host cells comprising the nucleic acids and methods for producing a subject antibody. The subject antibodies, nucleic acid compositions and kits find use in a variety of applications, including diagnostics and therapeutic treatment and research of conditions and diseases.

Claims

1. A method of humanizing a rabbit monoclonal antibody, said method comprising:

(a) comparing an amino acid sequences of a heavy an a light chain variable domain of a parent rabbit antibody to the amino acid sequence of a heavy and a light chain variable domain of a similar human antibody; and

(b) altering amino acids within the framework regions of said heavy and light chain variable domains of said rabbit antibody such that the altered framework regions are more similar in sequence to the equivalent framework regions of said similar human antibody;

wherein said altered amino acids are not involved in complementarity determining region (CDR) contacts, interchain contacts, or are buried residues with substantially different side chains.

2. The method of claim 1, wherein said light chain of said parent monoclonal antibody contains a CDR 3 that is at least one amino acid longer than the CDR3 of said human antibody.

3. The method of claim 1, wherein the specificity and affinity said parent rabbit antibody and said altered rabbit antibody is substantially identical.

4. The method according to claim 1, wherein said altered rabbit antibody is less immunogenic in a human host than said rabbit parent antibody.

5. The method of claim 1, wherein the framework region 1 of said parent rabbit monoclonal antibody is replaced by a framework region 1 of said human antibody to extend the length of said parent rabbit monoclonal antibody by one or more amino acids.

6. The method of claim 1, wherein the VH D-E loop of said parent rabbit monoclonal antibody is replaced by a DE loop from said human antibody to extend the length of said D-E loop of said parent rabbit monoclonal by one or more amino acids.

7. The method of claim 1, wherein any VK cysteine residue at position 80 of said parent rabbit monoclonal antibody is replaced by an amino acid found at position 80 of said human antibody.

8. The method of claim 1, wherein the VK E-F loop of said parent rabbit monoclonal antibody is replaced by a E-F loop from said human antibody.

9. The method of claim 1, wherein pairs of cysteines that are situated in close proximity to each other in said parent monoclonal antibody are replaced by amino acids found at the same positions of said human antibody.

10. A rabbit monoclonal antibody humanized by the method set forth in claim 1.

11. The humanized rabbit monoclonal antibody of claim 13, wherein said antibody has a measured binding affinity of 2×

10⁷ M<sup>−

1</sup> or greater for an antigen that is bound with a binding affinity of 10⁸ M<sup>−

1</sup> or greater by said parent rabbit antibody.

12. The modified rabbit antibody according to claim 10, wherein said antibody is not linked to a fragment of a viral polypeptide.

13. The modified rabbit antibody according to claim 10, wherein said antibody is an antibody fragment.

14. A nucleic acid encoding a heavy or light chain variable domain of the monoclonal antibody set forth in claim 10.

15. A vector comprising the nucleic acid of claim 14.

16. A host cell comprising the vector according to claim 15.

17. A method of producing a humanized rabbit antibody, said method comprising:

incubating the host cell of claim 16 under conditions sufficient to produce said antibody; and

harvesting said antibody.

18. A kit containing:

a monoclonal antibody humanized by the method of claim 1;

and

instructions for using the monoclonal antibody to for treatment of a condition.

19. A computer-readable medium encoding instructions to direct a processor to perform the method of claim 1.

20. A kit for use in a computer, said kit comprising:

(a) a computer-readable medium according to claim 19;

and

(b) instructions for operating said computer according to said programming.